Zoetis (ZTS) |
United States |
$45.440B |
30.23 |
Takeda Pharmaceutical (TAK) |
Japan |
$31.638B |
11.70 |
Grifols (GRFS) |
Spain |
$13.559B |
16.43 |
Ionis Pharmaceuticals (IONS) |
United States |
$8.053B |
0.00 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$7.660B |
10.99 |
Nektar Therapeutics (NKTR) |
United States |
$7.410B |
10.62 |
Neurocrine Biosciences (NBIX) |
United States |
$7.347B |
475.82 |
Tilray (TLRY) |
United States |
$7.176B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$7.171B |
0.00 |
Catalent (CTLT) |
United States |
$6.152B |
25.76 |
United Therapeutics (UTHR) |
United States |
$5.177B |
8.47 |
FibroGen (FGEN) |
United States |
$4.896B |
0.00 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$4.183B |
22.24 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$4.119B |
13.26 |
USANA Health Sciences (USNA) |
United States |
$2.535B |
20.69 |
Endo (ENDP) |
Ireland |
$2.403B |
3.68 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$2.251B |
0.00 |
Heron Therapeutics (HRTX) |
United States |
$2.137B |
0.00 |
Portola Pharmaceuticals (PTLA) |
United States |
$2.081B |
0.00 |
Madrigal Pharmaceuticals (MDGL) |
United States |
$2.067B |
0.00 |
Xencor (XNCR) |
United States |
$2.029B |
0.00 |
Zogenix (ZGNX) |
United States |
$1.994B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$1.968B |
24.51 |
Aerie Pharmaceuticals (AERI) |
United States |
$1.855B |
0.00 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$1.708B |
0.00 |
PTC Therapeutics (PTCT) |
United States |
$1.707B |
0.00 |
Pacira Pharmaceuticals (PCRX) |
United States |
$1.642B |
221.89 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.491B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$1.425B |
0.00 |
Corcept Therapeutics (CORT) |
United States |
$1.324B |
19.44 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$1.253B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$1.167B |
0.00 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$0.979B |
0.00 |
Tricida (TCDA) |
United States |
$0.964B |
0.00 |
Radius Health (RDUS) |
United States |
$0.844B |
0.00 |
ImmunoGen (IMGN) |
United States |
$0.824B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$0.587B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.566B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.557B |
0.00 |
ChemoCentryx (CCXI) |
United States |
$0.547B |
43.28 |
Flexion Therapeutics (FLXN) |
United States |
$0.542B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$0.530B |
0.00 |
BioSpecifics Technologies Corp (BSTC) |
United States |
$0.520B |
30.69 |
GlycoMimetics (GLYC) |
United States |
$0.502B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.500B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.493B |
0.00 |
Forty Seven (FTSV) |
United States |
$0.468B |
0.00 |
Odonate Therapeutics (ODT) |
United States |
$0.447B |
0.00 |
Aptorum Group (APM) |
China |
$0.429B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.398B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.375B |
3.49 |
Translate Bio (TBIO) |
United States |
$0.375B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.374B |
0.00 |
HARPOON THERAPT (HARP) |
United States |
$0.361B |
0.00 |
CASI Pharmaceuticals (CASI) |
United States |
$0.359B |
0.00 |
ArQule (ARQL) |
United States |
$0.353B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.353B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.349B |
0.00 |
Tyme Technologies (TYME) |
United States |
$0.329B |
0.00 |
Dermira (DERM) |
United States |
$0.320B |
0.00 |
OptiNose (OPTN) |
United States |
$0.301B |
0.00 |
Majesco Entertainment (PTE) |
United States |
$0.297B |
0.00 |
ASSERTIO THERAPEUTICS, INC (ASRT) |
United States |
$0.286B |
10.67 |
Verrica Pharmaceuticals (VRCA) |
United States |
$0.285B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.282B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.280B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.263B |
0.00 |
Mast Therapeutics (SVRA) |
United States |
$0.239B |
0.00 |
Opexa Therapeutics (ACER) |
United States |
$0.233B |
0.00 |
Dova Pharmaceuticals (DOVA) |
United States |
$0.232B |
0.00 |
IMV INC (IMV) |
Canada |
$0.220B |
0.00 |
Affimed (AFMD) |
Germany |
$0.215B |
0.00 |
Aratana Therapeutics (PETX) |
United States |
$0.214B |
0.00 |
Galectin Therapeutics (GALT) |
United States |
$0.214B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.214B |
0.00 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.209B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.206B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.204B |
0.00 |
Foamix Pharmaceuticals (FOMX) |
Israel |
$0.200B |
0.00 |
Aldeyra Therapeutics (ALDX) |
United States |
$0.200B |
0.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.196B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.195B |
0.00 |
Taiwan Liposome, Unsponsored ADR (TLC) |
Taiwan |
$0.191B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.186B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.177B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.176B |
0.00 |
AgeX Therapeutics (AGE) |
United States |
$0.172B |
0.00 |
Zafgen (ZFGN) |
United States |
$0.168B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.165B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.164B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.162B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.158B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$0.153B |
0.00 |
Marinus Pharmaceuticals (MRNS) |
United States |
$0.152B |
0.00 |
Adherex Technologies (FENC) |
United States |
$0.149B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.143B |
0.00 |
Jounce Therapeutics (JNCE) |
United States |
$0.137B |
0.00 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.136B |
0.00 |
Neon Therapeutics (NTGN) |
United States |
$0.131B |
0.00 |
MediWound (MDWD) |
Israel |
$0.131B |
0.00 |
Cardiome Pharma (CORV) |
Canada |
$0.129B |
0.00 |
DURECT (DRRX) |
United States |
$0.127B |
0.00 |
ProNAi Therapeutics (SRRA) |
Canada |
$0.126B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.120B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.119B |
0.00 |
Matinas Biopharma Holdings (MTNB) |
United States |
$0.117B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.107B |
0.00 |
Oasmia Pharmaceutical AB (OASM) |
Sweden |
$0.100B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.089B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.084B |
8.17 |
Nivalis Therapeutics (ALPN) |
United States |
$0.082B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.081B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.081B |
0.00 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.081B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.079B |
0.00 |
Synergy Pharmaceuticals (SGYP) |
United States |
$0.078B |
0.00 |
Neos Therapeutics (NEOS) |
United States |
$0.073B |
0.00 |
Melinta Therapeutics (MLNT) |
United States |
$0.069B |
0.00 |
Ampio Pharmaceuticals (AMPE) |
United States |
$0.067B |
0.00 |
Immune Design (IMDZ) |
United States |
$0.067B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.066B |
0.00 |
Actinium Pharmaceuticals (ATNM) |
United States |
$0.065B |
0.00 |
Avenue Therapeutics (ATXI) |
United States |
$0.063B |
0.00 |
Zomedica Pharmaceuticals (ZOM) |
United States |
$0.062B |
0.00 |
Tetraphase Pharmaceuticals (TTPH) |
United States |
$0.062B |
0.00 |
Otonomy (OTIC) |
United States |
$0.061B |
0.00 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.061B |
0.00 |
KemPharm (KMPH) |
United States |
$0.061B |
0.00 |
Forward Pharma (FWP) |
Denmark |
$0.060B |
0.00 |
CTI BioPharma (CTIC) |
United States |
$0.055B |
0.00 |
Mannatechorporated (MTEX) |
United States |
$0.045B |
0.00 |
Genocea Biosciences (GNCA) |
United States |
$0.045B |
0.00 |
Achaogen (AKAO) |
United States |
$0.043B |
0.00 |
BioLineRx (BLRX) |
Israel |
$0.043B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.042B |
0.00 |
Tokai Pharmaceuticals (NVUS) |
United States |
$0.040B |
0.00 |
ContraFect (CFRX) |
United States |
$0.038B |
0.00 |
Lipocine (LPCN) |
United States |
$0.036B |
0.00 |
Capnia (SLNO) |
United States |
$0.036B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.035B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.034B |
0.00 |
NOVAN INC (NOVN) |
United States |
$0.031B |
0.00 |
NanoViricides (NNVC) |
United States |
$0.030B |
0.00 |
NovaBay Pharmaceuticals (NBY) |
United States |
$0.027B |
0.00 |
PharmAthene (ALT) |
United States |
$0.026B |
0.00 |
IsoRay (ISR) |
United States |
$0.025B |
0.00 |
ESSA Pharma (EPIX) |
Canada |
$0.023B |
0.00 |
Biomerica (BMRA) |
United States |
$0.023B |
0.00 |
Can-Fite Biopharma (CANF) |
Israel |
$0.023B |
0.00 |
Citius Pharmaceuticals (CTXR) |
United States |
$0.021B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.020B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.020B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.020B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.020B |
0.00 |
Pain Therapeutics (PTIE) |
United States |
$0.019B |
0.00 |
Trillium Therapeutics (TRIL) |
Canada |
$0.018B |
0.00 |
CollPlant Holdings Sponsored ADR (CLGN) |
Israel |
$0.018B |
0.00 |
HANCOCK JAFFE (HJLI) |
United States |
$0.018B |
0.00 |
Summit Therapeutics (SMMT) |
United Kingdom |
$0.018B |
0.00 |
Kitov Pharmaceuticals Holdings (KTOV) |
Israel |
$0.018B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.016B |
0.00 |
Auris Medical Holding AG (EARS) |
Switzerland |
$0.014B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.014B |
0.00 |
PRECISION THERAPEUTICS INC (AIPT) |
United States |
$0.013B |
0.00 |
XTL Biopharmaceuticals (XTLB) |
Israel |
$0.012B |
0.00 |
Shineco (TYHT) |
China |
$0.012B |
1.32 |
OncoGenex Pharmaceuticals (ACHV) |
United States |
$0.012B |
0.00 |
DelMar Pharmaceuticals (DMPI) |
Canada |
$0.010B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.009B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.007B |
0.00 |
Intellipharmaceutics (IPCI) |
Canada |
$0.007B |
0.00 |
Ohr Pharmaceuticals (OHRP) |
United States |
$0.006B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.005B |
0.00 |
Bio Blast Pharma (ORPN) |
Israel |
$0.005B |
0.00 |
Ritter Pharmaceuticals (RTTR) |
United States |
$0.004B |
0.00 |
Midatech Pharma (MTP) |
United Kingdom |
$0.004B |
0.00 |
Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.003B |
0.00 |
Bio-Path Holdings (BPTH) |
United States |
$0.002B |
0.00 |
Advanced Accelerator Applications (AAAP) |
France |
$0.000B |
0.00 |
Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |